Search Results - "DAE YOUNG ZANG" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach

Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach

by Lee, Jun Haeng, Kim, Jae G, Jung, Hye-Kyung, Kim, Jung Hoon, Jeong, Woo Kyoung, Jeon, Tae Joo, Kim, Joon Mee, Kim, Young Il, Ryu, Keun Won, Kong, Seong-Ho, Kim, Hyoung-Il, Jung, Hwoon-Yong, Kim, Yong Sik, Zang, Dae Young, Cho, Jae Yong, Park, Joon Oh, Lim, Do Hoon, Jung, Eun Sun, Ahn, Hyeong Sik, Kim, Hyun Jung
Published in Journal of gastric cancer (01.06.2014)

Get full text

Journal Article

Varlitinib and Paclitaxel for EGFR/HER2 Co-Expressing Advanced Gastric Cancer: a Multicenter Phase Ib/II Study (K-MASTER-13)

Varlitinib and Paclitaxel for EGFR/HER2 Co-Expressing Advanced Gastric Cancer: a Multicenter Phase Ib/II Study (K-MASTER-13)

by Koo, Dong-Hoe, Jung, Minkyu, Kim, Yeul Hong, Jeung, Hei-Cheul, Zang, Dae Young, Bae, Woo Kyun, Kim, Hyunki, Kim, Hyo Song, Lee, Choong-Kun, Kwon, Woo Sun, Chung, Hyun Cheol, Rha, Sun Young
Published in Cancer research and treatment (01.10.2024)

Get full text

Journal Article

Appropriate Starting Dose of Dasatinib Based on Analyses of Dose-Limiting Toxicities and Molecular Responses in Asian Patients With Chronic Myeloid Leukemia

Appropriate Starting Dose of Dasatinib Based on Analyses of Dose-Limiting Toxicities and Molecular Responses in Asian Patients With Chronic Myeloid Leukemia

by Shin, Hyejin, Ha, Jung-Eun, Zang, Dae Young, Kim, Sung-Hyun, Do, Young Rok, Lee, Won Sik, Kim, Dong-Wook, Lee, Jangik I.
Published in Clinical lymphoma, myeloma and leukemia (01.06.2021)

Get full text

Journal Article

The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group

The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group

by Kim, Bum Jun, Maeng, Chi Hoon, Keam, Bhumsuk, Im, Young-Hyuck, Ro, Jungsil, Jung, Kyung Hae, Im, Seock-Ah, Kim, Tae Won, Lee, Jae Lyun, Heo, Dae Seog, Kim, Sang-We, Park, Keunchil, Ahn, Myung-Ju, Cho, Byoung Chul, Kim, Hoon-Kyo, Kang, Yoon-Koo, Cho, Jae Yong, Yun, Hwan Jung, Nam, Byung-Ho, Zang, Dae Young
Published in Cancer research and treatment (10.07.2024)

Get full text

Journal Article

Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)

Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)

by Lee, Sung-Eun, Park, Joon Seong, Kim, Hyeoung-Joon, Kim, Sung-Hyun, Zang, Dae Young, Oh, Sukjoong, Do, Young Rok, Choi, Yunsuk, Kwak, Jae-Yong, Kim, Jeong-A, Lee, Kyoo Hyung, Mun, Yeung-Chul, Lee, Won Sik, Chang, Myung Hee, Park, Jinny, Kwon, Jihyun, Kim, Dong-Wook
Published in Blood (13.11.2019)

Get full text

Journal Article

Tumor response assessment by measuring the single largest lesion per organ in patients with advanced gastric cancer or colorectal cancer

Tumor response assessment by measuring the single largest lesion per organ in patients with advanced gastric cancer or colorectal cancer

by Kim, Jung Han, Jang, Hyun Joo, Kim, Hyeong Su, Song, Hun Ho, Zang, Dae Young
Published in Journal of clinical oncology (20.01.2015)

Get full text

Journal Article

ARTIST 2: Interim results of a phase III trial involving adjuvant chemotherapy and/or chemoradiotherapy after D2-gastrectomy in stage II/III gastric cancer (GC)

ARTIST 2: Interim results of a phase III trial involving adjuvant chemotherapy and/or chemoradiotherapy after D2-gastrectomy in stage II/III gastric cancer (GC)

by Park, Se Hoon, Zang, Dae Young, Han, Boram, Ji, Jun Ho, Kim, Tae Gyu, Oh, Sung Yong, Hwang, In Gyu, Kim, Jung Hoon, Shin, Dongbok, Lim, Do Hoon, Kim, Kyoung Mee, An, Ji Yeong, Choi, Min-Gew, Lee, Jun-Ho, Sohn, Tae Sung, Bae, Jae-Moon, Kim, Sung, Kim, Seung, Lee, Jeeyun, Kang, Won Ki
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

A Randomized Trial Comparing Cisplatin Plus 5-fluorouracil With or Without Levamisole in Operable Gastric Cancer

A Randomized Trial Comparing Cisplatin Plus 5-fluorouracil With or Without Levamisole in Operable Gastric Cancer

by Jong Soo Choi, Kyoo Hyung Lee, Myung Ju Ahn, Jung Shin Lee, Je Han Lee, Dae Young Zang, Chel Won Suh, Sang We Kim, Woo Gun Kim, Jin Cheon Kim, Suk Koo Kim, Kun Choon Park, Moo Song Lee, Sa
Published in The Korean journal of internal medicine (30.06.1997)

Get full text

Journal Article

The Impact of Early Molecular Response at 3 Months on Long-Term Survival Was Enhanced in the CP CML Patients Treated with Second-Generation Tyrosine Kinase Inhibitors

The Impact of Early Molecular Response at 3 Months on Long-Term Survival Was Enhanced in the CP CML Patients Treated with Second-Generation Tyrosine Kinase Inhibitors

by Lee, Sung-Eun, Lee, Won-Sik, Kim, Hyeoung-Joon, Kong, Jee Hyun, Choi, Yunsuk, Do, Young Rok, Kwak, Jae-Yong, Oh, Sukjoong, Kim, Sung-Hyun, Kim, Jeong-A, Zang, Dae Young, Mun, Yeung-Chul, Won, Young-Woong, Kim, Dong-Wook
Published in Blood (08.12.2017)

Get full text

Journal Article

ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group

ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group

by Yoon, Shinkyo, Kim, Miso, Hong, Yong Sang, Kim, Han Sang, Kim, Seung Tae, Kim, Jihun, Yun, Hongseok, Yoo, Changhoon, Ahn, Hee Kyung, Kim, Hyo Song, Lee, In Hee, Kim, In-Ho, Park, Inkeun, Jeong, Jae Ho, Cheon, Jaekyung, Kim, Jin Won, Yun, Jina, Lim, Sun Min, Cha, Yongjun, Jang, Se Jin, Zang, Dae Young, Kim, Tae Won, Kang, Jin Hyoung, Kim, Jee Hyun
Published in Cancer research and treatment (01.07.2023)

Get full text

Journal Article

Final Study Results of Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 48 Months Follow-up

Final Study Results of Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 48 Months Follow-up

by Do, Young Rok, Kwak, Jae-Yong, Kim, Hawk, Kim, Jeong-A, Kim, Hyeoung-Joon, Park, Joon Seong, Chung, Jooseop, Shin, Ho-Jin, Kim, Sung-Hyun, Bunworasate, Udomsak, Choi, Chul Won, Comia, Narcisa Sonia Cornejo, Zang, Dae Young, Oh, Sukjoong, Jootar, Saengsuree, Reksodiputro, Ary Harryanto, Lee, Won-Sik, Mun, Yeung-Chul, Kong, Jee Hyun, Caguioa, Priscilla B., Park, Jinny, Jung, Chul W., Kim, Dong-Wook
Published in Blood (29.11.2018)

Get full text

Journal Article

A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10)

A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10)

by Lee, Keun-Wook, Zang, Dae Young, Ryu, Min-Hee, Han, Hye Sook, Kim, Ki Hyang, Kim, Mi-Jung, Koh, Sung Ae, Lee, Sung Sook, Koo, Dong-Hoe, Ko, Yoon Ho, Sohn, Byeong Seok, Kim, Jin Won, Park, Jin Hyun, Nam, Byung-Ho, Choi, In Sil
Published in Cancer research and treatment (01.10.2023)

Get full text

Journal Article

Results from the safety interim analysis of the Adjuvant chemoRadioTherapy In Stomach Tumors 2 (ARTIST 2) randomized, multi-center clinical trial

Results from the safety interim analysis of the Adjuvant chemoRadioTherapy In Stomach Tumors 2 (ARTIST 2) randomized, multi-center clinical trial

by Park, Se Hoon, Lee, Jeeyun, Lim, Do Hoon, Kim, Kyoung-Mee, An, Ji Yeong, Choi, Min-Gew, Lee, Jun-Ho, Sohn, Tae Sung, Bae, Jae-Moon, Kim, Sung, Ji, Jun Ho, Hwang, In Gyu, Kang, Jung Hun, Zang, Dae Young, Shin, Dong Bok, Oh, Sung Yong, Kang, Won Ki
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article

Impact of Body Weight Adjusted Dose on Efficacy and Safety of Radotinib in Chronic Myeloid Leukemia

Impact of Body Weight Adjusted Dose on Efficacy and Safety of Radotinib in Chronic Myeloid Leukemia

by Noh, Hayeon, Jung, Su Young, Kwak, Jae-Yong, Kim, Sung-Hyun, Oh, Suk Joong, Zang, Dae Young, Park, Hye Lin, Jo, Dae Jin, Shin, Jae Soo, Do, Young Rok, Kim, Dong-Wook, Lee, Jangik I
Published in Blood (02.12.2016)

Get full text

Journal Article

Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group

Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group

by Yoon, Shinkyo, Kim, Miso, Hong, Yong Sang, Kim, Han Sang, Kim, Seung Tae, Kim, Jihun, Yun, Hongseok, Yoo, Changhoon, Ahn, Hee Kyung, Kim, Hyo Song, Lee, In Hee, Kim, In-Ho, Park, Inkeun, Jeong, Jae Ho, Cheon, Jaekyung, Kim, Jin Won, Yun, Jina, Lim, Sun Min, Cha, Yongjun, Jang, Se Jin, Zang, Dae Young, Kim, Tae Won, Kang, Jin Hyoung, Kim, Jee Hyun
Published in Cancer research and treatment (01.01.2022)

Get full text

Journal Article

Deeper Molecular Response in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 36 Months Follow-up

Deeper Molecular Response in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 36 Months Follow-up

by Do, Young Rok, Kim, Hawk, Kwak, Jae-Yong, Kim, Jeong-A, Kim, Hyeoung-Joon, Park, Joon Seong, Chung, Jooseop, Shin, Ho-Jin, Kim, Sung-Hyun, Bunworasate, Udomsak, Choi, Chul Won, Comia, Narcisa Sonia Cornejo, Zang, Dae Young, Oh, Sukjoong, Jootar, Saengsuree, Reksodiputro, Ary Harryanto, Lee, Won-Sik, Mun, Yeung-Chul, Kong, Jee Hyun, Caguioa, Priscilla B., Park, Jinny, Jung, Chul W., Kim, Dong-Wook
Published in Blood (08.12.2017)

Get full text

Journal Article

Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

by Lee, Won-Sik, Song, Hye-Young, Kim, Hyeoung-Joon, Kong, Jee Hyun, Do, Young Rok, Kwak, Jae-Yong, Oh, Sukjoong, Kim, Sung-Hyun, Kim, Jeong-A, Zang, Dae Young, Mun, Yeung-Chul, Won, Young-Woong, Lee, Sung-Eun, Choi, Yunsuk, Kim, Dong-Wook
Published in Blood (08.12.2017)

Get full text

Journal Article

Characterization of ABL Compound Mutation Using Sanger and Subcloning Sequencing in Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia

Characterization of ABL Compound Mutation Using Sanger and Subcloning Sequencing in Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia

by Oh, Sukjoong, Kang, Ki Hoon, Lee, Won-Sik, Kim, Hyeoung-Joon, Kong, Jee Hyun, Choi, Yunsuk, Do, Young Rok, Kwak, Jae-Yong, Kim, Sung-Hyun, Kim, Jeong-A, Zang, Dae Young, Mun, Yeung-Chul, Won, Young-Woong, Lee, Sung-Eun, Kim, Dong-Wook
Published in Blood (08.12.2017)

Get full text

Journal Article

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

by Jo, Jungmin, Bae, Sung Hwa, Park, Jinny, Lee, Hong-ghi, Choi, Chul Won, Park, Yong, Lee, Ho Sup, Kim, Sung-Hyun, Lee, Won-Sik, Bang, Soo-Mee, Jang, Jun-Ho, Kim, Inho, Lee, Je-Hwan, Cheong, June-Won, Park, Seong Kyu, Won, Jong-Ho, Kim, Min Kyoung, Shim, Hyeok, Mun, Yeung-Chul, Ahn, Jae-Sook, Jo, Deog-Yeon, Zang, Dae Young
Published in Blood (08.12.2017)

Get full text

Journal Article

Clinical Outcome and Predictive Factors in the Response to Splenectomy in Elderly Patients with Primary Immune Thrombocytopenia: A Multicenter Retrospective Study

Clinical Outcome and Predictive Factors in the Response to Splenectomy in Elderly Patients with Primary Immune Thrombocytopenia: A Multicenter Retrospective Study

by Park, Young Hoon, Yi, Hyeon Gyu, Kim, Chul Soo, Hong, Junshik, Park, Jinny, Lee, Jae Hoon, Kim, Ho Young, Kim, Hyo Jung, Zang, Dae Young, Kim, Se Hyung, Park, Seong Kyu, Hong, Dae Sik, Lee, Guk Jin, Jin, Jong-Youl
Published in Acta haematologica (01.01.2016)

Get more information

Journal Article

[1]
Prev
3
4
5
6
7
8
9
10
11
12
13
Next
[14]